home / stock / clabf / clabf news

CLABF News and Press, Core One Labs Inc.

Stock Information
Company Name: Core One Labs Inc.
Stock Symbol: CLABF
Market: OTC
Website: lifestyledeliverysystem.com
Menu
CLABF CLABF Quote CLABF Short CLABF News CLABF Articles CLABF Message Board
Get CLABF Alerts

News, Short Squeeze, Breakout and More Instantly...
CLABF - Core One Enters into Loan Agreement with Right Season Investments

VANCOUVER, BC / ACCESSWIRE / July 8, 2024 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6 , WKN: A3CSSU ) (the " Company " or " Core One "), is pleased to announce that it has entered into a loan agreement (the " Loan Agreement ") with Right Season Investments Corp. (" Right S...
CLABF - Core One Labs signs initial agreement for potential sale of proprietary biosynthetic psilocybin

2023-12-11 04:21:42 ET More on Core One Labs Inc. Financial information for Core One Labs Inc. For further details see: Core One Labs signs initial agreement for potential sale of proprietary biosynthetic psilocybin

CLABF - Core One Labs Inc. Announces Initial Agreement for Potential Sale of Proprietary Biosynthetic Psilocybin, Facilitating Entry into the International Market

VANCOUVER, BC / ACCESSWIRE / December 8, 2023 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6 ) (WKN:A3CSSU) (the " Company " or " Core One ") is pleased to announce the signing of an Initial Agreement (the " Agreement ") with Cube Psytech Corp. (" Cube Psytech ") marking a sig...

CLABF - Core One Labs' Akome Reveals Impressive Results for its Psychedelic Bio-Compounds Designed to Target Alzheimer's and Parkinson's, Showing Potential to Outperform Current Treatment Methods

VANCOUVER, BC / ACCESSWIRE / December 1, 2023 / Core One Labs Inc. (" Core One " or the " Company ") (CNSX: COOL )(OTCQB: CLABF )(Frankfurt: LD6 ) (WKN: A3CSSU ), an emerging leader in the field of neuroscience and psychedelics, is delighted to share the exciting results of its first round of S...
CLABF - Core One's Akome Reveals Groundbreaking Positive Results from its Second Round of Stage 1 Animal Model Studies for Bio-Compounds Targeting Alzheimer's and Parkinson's Disease

VANCOUVER, BC / ACCESSWIRE / August 4, 2023 / Core One Labs Inc. (CSE: COOL ) (OTCQB: CLABF ) (Frankfurt: LD6 , WKN:A3CSSU), (the " Company " or " Core One ") is delighted to announce the receipt of additional positive results from its second round (" Round 2 ") of Stage 1 animal model studies. ...

CLABF - Core One Labs', Awakened Biosciences, Announces Groundbreaking Step Forward in Isolating and Purifying Psilocybin from Mushroom Biomass

Core One's Wholly-Owned Subsidiary has filed a patent application with the United States Patent and Trademark Office VANCOUVER, BC / ACCESSWIRE / August 1, 2023 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6 , WKN:A3CSSU) (the " Company " or " Core One ") proudly announces a...

CLABF - Core One's Akome Receives Positive Preliminary Stage 1 Animal Model Study Results for Bio-Compound Targeting Alzheimer's and Parkinson's Disease

VANCOUVER, BC / ACCESSWIRE / July 28, 2023 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6) (WKN:A3CSSU) (the " Company " or " Core One "), is excited to share positive results from its first round of Stage 1 animal model studies (" Round 1"), conducted by its research partners...
CLABF - Core One Labs Enters into Letter of Intent for First Sale of Its Psychedelic Compounds

VANCOUVER, BC / ACCESSWIRE / July 21, 2023 / Core One Labs Inc. (CSE: COOL )(OTCQB: CLABF )(Frankfurt: LD6 ) (WKN: A3CSSU) (the " Company " or " Core One ") is pleased to announce that its wholly-owned subsidiary, GMP Drug Inc. (" GMP Drug "), has entered into a non-binding letter of intent ...

CLABF - Core One's Vocan Biotechnologies Incorporates New Bioreactor Equipment into Production Process Significantly Increasing Throughput of Proprietary Biosynthetic Psilocybin

VANCOUVER, BC / ACCESSWIRE / July 11, 2023 / Core One Labs Inc. (CSE: COOL ), (OTCQB: CLABF ), (Frankfurt: LD6 , WKN: A3CSSU ) (the " Company ") is pleased to announce that its wholly-owned subsidiary Vocan Biotechnologies Inc. (" Vocan ") has incorporated a state-of-the-art, high density, fer...

CLABF - Core One's Vocan Files International Patent for its Breakthrough Proprietary Biosynthetic Psilocybin Production Method

VANCOUVER, BC / ACCESSWIRE / July 7, 2023 / Core One Labs Inc. (CSE: COOL ), (OTCQB: CLABF ), (Frankfurt: LD6 ), (WKN: A3CSSU) (the " Company " or " Core One ") is pleased to announce that its wholly owned subsidiary, Vocan Biotechnologies Inc. (" Vocan "), has completed final steps of its r...
Next 10